NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE

NIH RePORTER · NIH · N02 · $639,151 · view on reporter.nih.gov ↗

Abstract

NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE AND STUDY THE SHELF-LIFE.

Key facts

NIH application ID
10710314
Project number
75N98019D00058-0-759102200003-1
Recipient
IRISYS, INC.
Principal Investigator
ROBERT GIANNINI
Activity code
N02
Funding institute
NIH
Fiscal year
2022
Award amount
$639,151
Award type
Project period
2022-04-11 → 2026-04-10